Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management
JS Knight, DW Branch, TL Ortel - bmj, 2023 - bmj.com
Antiphospholipid syndrome (APS) is a thrombo-inflammatory disease propelled by
circulating autoantibodies that recognize cell surface phospholipids and phospholipid …
circulating autoantibodies that recognize cell surface phospholipids and phospholipid …
Prevalence and adverse consequences of delayed diagnosis and misdiagnosis in thrombotic antiphospholipid syndrome. An observational cohort study and a review …
A Ruffatti, M Tonello, A Calligaro, T Del Ross… - Clinical …, 2023 - Springer
Obiectives This study aims to prospectively evaluate the frequency and adverse
consequences of diagnostic delay and misdiagnosis in a cohort of patients with thrombotic …
consequences of diagnostic delay and misdiagnosis in a cohort of patients with thrombotic …
Description of damage in different clusters of patients with antiphospholipid syndrome
Objective To identify the different clinical phenotypes of antiphospholipid syndrome (APS) by
using cluster analysis and describe cumulative damage of disease clusters. Methods This …
using cluster analysis and describe cumulative damage of disease clusters. Methods This …
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry
Objectives Our primary objective was to quantify damage burden measured by Damage
Index for Antiphospholipid Syndrome (DIAPS) in aPL-positive patients with or without a …
Index for Antiphospholipid Syndrome (DIAPS) in aPL-positive patients with or without a …
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centres.
L Moschetti, L Dal Pozzolo, V Le Guern, N Morel… - 2022 - lilloa.univ-lille.fr
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433
patients from four European centres Page 1 S-19 Clinical and Experimental Rheumatology …
patients from four European centres Page 1 S-19 Clinical and Experimental Rheumatology …
Epidemiology of antiphospholipid syndrome: macro-and microvascular manifestations
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
thrombotic and non-thrombotic macro-and microvascular manifestations and pregnancy …
thrombotic and non-thrombotic macro-and microvascular manifestations and pregnancy …
Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series
JA Madison, K Gockman, C Hoy, A Tambralli… - Pediatric …, 2022 - Springer
Background/purpose Pediatric antiphospholipid syndrome (APS) is a thromboinflammatory
disease characterized by the presence of circulating antiphospholipid antibodies and either …
disease characterized by the presence of circulating antiphospholipid antibodies and either …
Risk factors for damage accrual in primary antiphospholipid syndrome: A retrospective single-center cohort study
A Hoxha, N Perin, M Lovisotto, A Calligaro… - Journal of …, 2024 - Elsevier
Background Despite anticoagulant therapy, a antiphospholipid syndrome (APS) has a
higher rate of recurrent events, which can lead to damage accrual and a negative impact on …
higher rate of recurrent events, which can lead to damage accrual and a negative impact on …
A one-point increase in the Damage Index for Antiphospholipid Syndrome (DIAPS) predicts mortality in thrombotic antiphospholipid syndrome
P Gaspar, F Farinha, Z Sayar… - Clinical and …, 2022 - discovery.ucl.ac.uk
OBJECTIVES: To determine whether early damage and its kinetics measured by the
Damage Index for Antiphospholipid Syndrome (DIAPS) predicts mortality. METHODS: We …
Damage Index for Antiphospholipid Syndrome (DIAPS) predicts mortality. METHODS: We …
The adjusted Global Anti-Phospholipid Syndrome Score as predictor of damage accrual measured by Damage Index for APS: a longitudinal study
G Barilaro, C Della Rocca, A Esteves, R Cervera… - …, 2023 - academic.oup.com
Objective To analyse the association between the average 'adjusted'Global APS Score
(aGAPSS) over time, as a surrogate of disease activity, and change in Damage Index for …
(aGAPSS) over time, as a surrogate of disease activity, and change in Damage Index for …